For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| PET/CT Results With TOF/ Without TOF | 101 participants received diagnostic CT of the abdomen/upper abdomen with contrast medium within the PET/CT examination and 19 participants had diagnostic CT of the abdomen or upper abdomen without contrast medium due to elevated creatine or decreased GFR (glomerular filtration rate) or TSH (thyroid-stimulating hormone) levels. | 0 | None | 0 | 101 | 0 | 101 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hypotensive shock | SYSTEMATIC_ASSESSMENT | Cardiac disorders | ESUR guidelines | View |
| Cardiac arrest | SYSTEMATIC_ASSESSMENT | Cardiac disorders | ESUR guidelines | View |
| Respiratory arrest | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | ESUR guidelines | View |
| Convulsion | SYSTEMATIC_ASSESSMENT | Nervous system disorders | ESUR guidelines | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Severe vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | ESUR guidelines | View |
| Nausea, mild vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | ESUR guidelines | View |
| Marked urticaria | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | ESUR guidelines | View |
| Urticaria | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | ESUR guidelines | View |
| Itching | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | ESUR guidelines | View |
| Facial edema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | ESUR guidelines | View |
| Bronchospasm | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | ESUR guidelines | View |
| Laryngeal edema | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | ESUR guidelines | View |
| Vasovagal attack | SYSTEMATIC_ASSESSMENT | Nervous system disorders | ESUR guidelines | View |